The US Patent Office issues new patents every Tuesday. Australian assignees generally get two or three healthcare and biotech-related patents a week. Here are the 133 US patents relevant to Australia's Life Sciences sector that issued in 2014, for an issuance rate of 2.3 patents per week.
US Patent 8,921,374 |
Title: Itraconazole compositions and dosage forms, and methods of using the same
Issued: 30 December 2014 Assignee: Mayne Pharma (ASX: MYC) |
Description: This patent covers an itraconazone formulation with improved bioavailability.
|
US Patent 8,921,309 |
Description: This patent covers a a modified version of the lipopeptide antiobiotic friulimicin with modified acyl side chains.
|
US Patent 8,921,306 |
Description: This patent covers an improved version of nociceptin with better binding to its ligand, the opioid receptor-like-1 receptor.
|
US Patent 8,920,851 |
Title: Treatment of neurodegenerative diseases
Issued: 30 December 2014 Assignee: Velacor Therapeutics |
Description: This patent covers the use of selenium compounds to enhance the activity of phosphatase PP2A to inhibit phosphorylation of tau protein.
|
US Patent 8,920,806 |
Title: Method of modulating inflammatory response by downregulation of activin
Issued: 30 December 2014 Assignee: Paranta Biosciences |
Description: This patent covers antagonists to Actavin A as an anti-inflammatory target.
|
US Patent 8,920,803 |
Title: Immunotherapeutic method involving CD123 (IL-3R.alpha.) antibodies and immunostimulating complex
Issued: 30 December 2014 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers an anti-CD123 antibody adjuvanted by Iscomatrix for the treatment of hematoligic disorders.
|
US Patent 8,916,523 |
Title: VIP fragments and methods of use
Issued: 23 December 2014 Assignee: Vectus Biosystems (ASX: VBS) |
Description: This patent covers the use of vasoactive intestinal peptide (VIP) fragment in treating fibrosis and hypertension.
|
US Patent 8,916,166 |
Title: Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
Issued: 23 December 2014 Assignee: Oral Health CRC |
Description: This patent covers drug targets useful in eliminating P. gingivalis infection.
|
US Patent 8,912,225 |
Description: This patent covers a formulation of albendazole which works through VEGF inhibition to treat ovarian cancer.
|
US Patent 8,911,997 |
Title: Mammalian cell culture medium
Issued: 16 December 2014 Assignee: Queensland University of Technology |
Description: This patent covers a combination of vitronectin and IGF Binding Protein useful for propagating keratinocytes.
|
US Patent 8,911,745 |
Description: This patent covers a P. gingivalis vaccine.
|
US Patent 8,906,919 |
Title: Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers
Issued: 9 December 2014 Assignee: Ozteo Pty Ltd |
Description: This patent covers the use of sodium channel blockers in preventing tissue damage.
|
US Patent 8,906,912 |
Description: This patent covers a GABA.A receptor agonist with better properties than existing drugs for the treatment of anxiety.
|
US Patent 8,906,279 |
Title: Humanized antibodies with anti-tumor activity
Issued: 2 December 2014 Assignee: Teva Pharmaceuticals Australia |
Description: This patent covers an anti-cancer antibody.
|
US Patent 8,895,698 |
Title: Binding partners of antibodies specific for dendritic cell antigens
Issued: 25 November 2014 Assignee: Mater Hospital Brisbane |
Description: This patent covers epitopes on dendritic cells useful as immunomodulatory targets.
|
US Patent 8,895,019 |
Description: This patent covers drugs to treat P. gingivalis infection.
|
US Patent 8,889,695 |
Description: This patent covers heterocyclic compounds useful in the treatment of Parkinson's Disease.
|
US Patent 8,883,015 |
Description: This patent covers methods of creating a microneedle patch for drug and vaccine delivery.
|
US Patent 8,877,727 |
Title: Delivery of dsRNA to arthropods
Issued: 4 November 2014 Assignee: Commonwealth Scientific and Industrial Research Organisation |
Description: This patent covers a gene silencing method using double-stranded RNA.
|
US Patent 8,877,243 |
Description: This patent covers cross-linked hyaluronic acid gels with improved degradation characteristics.
|
US Patent 8,871,709 |
Title: Synthetic chimeric proteins comprising epidermal growth factor and vitronectin
Issued: 28 October 2014 Assignee: Queensland University of Technology |
Description: This patent recombinant proteins combining elements of IGF-I and vitronectin, for use in wound repair.
|
US Patent 8,871,272 |
Title: Layered nanoparticles
Issued: 28 October 2014 Assignee: Australian Nuclear Science & Technology Organisation |
Description: This patent covers core-shell ceramic nanoparticles for drug delivery.
|
US Patent 8,871,272 |
Title: Probiotic storage and delivery
Issued: 28 October 2014 Assignee: Commonwealth Scientific and Industrial Research Organisation |
Description: This patent covers a method of encapsulating probiotic bacteria in milk proteins and a starch or sugar in order to enable better gastrointestinal delivery.
|
US Patent 8,871,213 |
Title: Prevention, treatment and diagnosis of P. gingivalis infection
Issued: 28 October 2014 Assignee: Oral Health CRC |
Description: This patent covers a P. gingivalis vaccine.
|
US Patent 8,865,736 |
Description: This patent covers substituted benzamides and pyridylamides with antibacterial activity.
|
US Patent 8,859,627 |
Description: This patent covers an anti-microbial composition of farnesol and cetrimide.
|
US Patent 8,858,951 |
Title: Compositions for eliciting an immune response
Issued: 14 October 2014 Assignee: University of Queensland |
Description: This patent covers a DNA vaccine that works via the ubiquitin-proteosome pathway.
|
US Patent 8,858,939 |
Description: This patent covers the combination of gefitinib and methotrexate in treating ectopic pregnancy.
|
US Patent 8,252,641 |
Title: Polymer microgel beads and preparative method thereof
Issued: 7 October 2014 Assignee: University of Sydney |
Description: This patent covers polymer microgel beads incorporating nanomagnetic particles, useful in applications such the hyperthermic treatment of tissue.
|
US Patent 8,846,026 |
Title: Composition comprising immunogenic microparticles
Issued: 30 September 2014 Assignee: PX BioSolutions |
Description: This patent covers virus-sized microparticles, useful as vaccine material.
|
US Patent 8,841,420 |
Title: Synthetic peptide constructs for the diagnosis and treatment of periodontis associated with Porphyromonas gingivalis
Issued: 23 September 2014 Assignee: University of Melbourne |
Description: This patent covers a P. gingivalis vaccine.
|
US Patent 8,841,351 |
Description: This patent covers a rapid-drying antibacterial hand rub.
|
US Patent 8,841,342 |
Description: This patent covers the use of phosphorylated Vitamin E to improve the water solubility of pharmaceuticals.
|
US Patent 8,841,254 |
Title: Method for treatment of anxiety
Issued: 23 September 2014 Assignee: Florey Institute of Neuroscience and Mental Health |
Description: This patent covers the use of H3 relaxin and analogues thereof in the treatment of anxiety.
|
US Patent 8,835,629 |
Description: This patent covers analogues of Naamidine A, an imidazole alkaloid extracted from Leucetta sponges.
|
US Patent 8,835,609 |
Title: Antigen binding sites to non-functional oligomeric P2X7 receptors and methods of use thereof
Issued: 16 September 2014 Assignee: Biosceptre International |
Description: This patent covers the targets for various antibodies to P2X7 , useful in inducing apoptosis in cancer cells.
|
US Patent 8,835,478 |
Description: This patent covers the combination of albendazole and paclitaxel in treating cancer.
|
US Patent 8,834,872 |
Description: This patent covers antibodies to gastrointestinal cancer, administered in milk or egg products for better targeting.
|
US Patent 8,828,933 |
Title: Mutant tat proteins and uses thereof
Issued: 9 September 2014 Assignee: Queensland Institute of Medical Research |
Description: This protein covers mutants of the HIV protein tat, useful in inhibiting multiple steps in the HIV-1 replication cycle.
|
US Patent 8,828,435 |
Description: This patent covers a buccal drug delivery system.
|
US Patent 8,828,409 |
Title: Vaccine comprising recombinant CLPP protein of Streptococcus pneumoniae
Issued: 9 September 2014 Assignee: Adelaide Research & Innovation (50%), Sungkyunkwan University (50%) |
Description: This patent covers recombinant caseinolytic protease P as a vaccine for S. pneumoniae.
|
US Patent 8,822,644 |
Title: Method of treating cancer comprising a VEGF-B antagonist
Issued: 2 September 2014 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers antibodies for VEGF-B.
|
US Patent 8,822,509 |
Title: Pain-relieving compositions and uses therefor
Issued: 2 September 2014 Assignee: University of Queensland |
Description: This patent covers nitric oxide donors for the treatnenbt of diabetic neuropathy.
|
US Patent 8,822,416 |
Description: This patent covers a topical anesthetic for applications such as mulesing of sheep.
|
US Patent 8,822,409 |
Title: Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith
Issued: 2 September 2014 Assignee: Phylogica (ASX: PYC) |
Description: This patent covers peptides to inhibit AP-1 signalling.
|
US Patent 8,815,936 |
Title: Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
Issued: 26 August 2014 Assignee: NAD Life |
Description: This patent covers the combination of resveratol, a chelating agent and an anti-oxidant to prevent oxidative stress.
|
US Patent 8,815,298 |
Title: Therapeutic composition comprising honey or a honey derivative
Issued: 26 August 2014 Assignee: Medihoney Pty Ltd |
Description: This patent covers a formulation of honey suitable for wound care.
|
US Patent 8,815,291 |
Title: Particles comprising a releasable dopant therein
Issued: 26 August 2014 Assignee: Australian Nuclear Science & Technology Organisation |
Description: This patent covers a method to include a dopant, such as a hydrophobic material, into solid or gel particles without the use of toxic solvents.
|
US Patent 8,809,386 |
Title: Use of dynamin ring stabilizers
Issued: 19 August 2014 Assignee: Children's Medical Research Institute (50%), MassGeneral (US, 50%) |
Description: This patent covers drugs that can stablise dynamin, an enzyme that helps receptor-mediated endocytosis, and thereby treat kidney disease.
|
US Patent 8,809,301 |
Title: Surgical hydrogel
Issued: 19 August 2014 Assignee: Adelaide Research & Innovation (33%), Robinson Squidgel Ltd (NZ, 33%), University of Otago (NZ, 33%) |
Description: The patent covers a gel useful in reducing post-surgery sinus scarring, where the actives come from polymers found in squid and crab shell.
|
US Patent 8,808,751 |
Title: Methods for the preparation of biologically active compounds in nanoparticulate form
Issued: 19 August 2014 Assignee: iCeutica |
Description: This patent covers a method for dry-milling of pharmaceuticals to produce drug nanoparticles.
|
US Patent 8,808,716 |
Description: This patent covers an oil in water emulsion aerosol foam suitable for treating acute skin conditions, particularly acne and psoriasis.
|
US Patent 8,808,706 |
Title: Arthrospira-based compositions and uses thereof
Issued: 19 August 2014 Assignee: Biovite Australia |
Description: This patent covers a physiologically stressed version of the blue-green algae Arthrospira useful as an antibiotic.
|
US Patent 8,808,692 |
Title: Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
Issued: 19 August 2014 Assignee: CSL Ltd (ASX: CSL) |
Description: This patent covers the combination of antibodies plus saponin derivatives as an adjuvant.
|
US Patent 8,807,861 |
Description: This patent covers the delivery system for Acrux's transdermal testosterone.
|
US Patent 8,802,840 |
Title: Bicyclic nucleosides and nucleotides as therapeutic agents
Issued: 12 August 2014 Assignee: Biota |
Description: This patent covers bicyclic nucleosides and nucleotides for the treatmet of Hepatitis C infection.
|
US Patent 8,802,634 |
Description: This patent covers an inhibitor to CD-40 ligand, useful as an anti-inflammatory.
|
US Patent 8,802,625 |
Description: This patent covers the use of colony stimulating factor-1 protein (CSF-1) in promoting growth in premature-birthed warm blooded animals.
|
US Patent 8,802,408 |
Title: Process for preparing nutritional, therapeutic or organoleptic products from crude glycerol
Issued: 12 August 2014 Assignee: Bio Processing Australia |
Description: This patent covers the use of crude glycerol to grow yeast.
|
US Patent 8,802,135 |
Title: Delivery system for remote treatment of an animal
Issued: 12 August 2014 Assignee: Smartvet Pty Ltd |
Description: This patent covers a gun to deliver doses to an animal remotely.
|
US Patent 8,802,116 |
Title: Poloxamer emulsion preparations
Issued: 12 August 2014 Assignee: Novasel Pty Ltd (Steen Jorsal) |
Description: This patent covers a microemulsion delivery systems for tea tree oil that does not require high temperature for .
|
US Patent 8,796,273 |
Description: This patent covers small molecules for the treatment of enterovirus infection.
|
US Patent 8,796,225 |
Title: Regulation of immune responses by modulation of the function of antigen presenting cells
Issued: 5 August 2014 Assignee: Invion (ASX: IVX) |
Description: This patent covers chaperonin 10 polypeptides, useful for modulating cell surface expression of MHC molecules.
|
US Patent 8,790,909 |
Description: This patent covers a safe strain of H. pylori as a tool for biological delivery vehicle for peptides.
|
US Patent 8,790,889 |
Description: This patent covers the production of adult hippocampal precursors bynorepinephrine in neurosphere-forming media.
|
US Patent 8,785,478 |
Description: This patent covers Hepatitis C virus polymerase inhibitors.
|
US Patent 8,785,140 |
Title: Cd4+ Cd25+ T-cells activated to a specific antigen
Issued: 22 July 2014 Assignee: University of New South Wales |
Description: This patent covers methods to grow regulatory T cells to a specific antigen to promote immune tolerance.
|
US Patent 8,784,878 |
Title: Transdermal delivery rate control using amorphous pharmaceutical compositions
Issued: 22 July 2014 Assignee: Acrux (ASX: ACR) |
Description: This patent covers the use of dermal penetration enhancers to control the rate of transdermal drug delivery.
|
US Patent 8,784,831 |
Title: P. gingivalis antigenic composition
Issued: 22 July 2014 Assignee: CSL Ltd (ASX: CSL), University of Melbourne (50%) |
Description: This patent covers antigenic peptides for use in a P. gingivalis vaccine.
|
US Patent 8,779,107 |
Title: Composition for targeting dendritic cells
Issued: 15 July 2014 Assignee: Lipotek (50%), GSK (50%) |
Description: This patent covers single domain antibodies to DC-SIGN, a dendritic cell antigen, for delivery of vaccine material to the dendritic cells.
|
US Patent 8,778,400 |
Title: Nanoparticle-stabilized capsule formulation for treatment of inflammation
Issued: 15 July 2014 Assignee: University of South Australia |
Description: This patent covers a nanoparticle-stabilised capsule formulation of celecoxib, which improves the drug;s bioavailability.
|
US Patent 8,778,300 |
Title: Method of forming an injectable radioactive composition of a carbon encapsulated radioactive particulate
Issued: 15 July 2014 Assignee: Australian National University |
Description: This patent covers an improved radioactive composite product for diagnostic imaging.
|
US Patent 8,772,013 |
Title: Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
Issued: 8 July 2014 Assignee: EnGeneIC |
Description: This patent covers drug delivery using EnGeneIC's 'minicells'.
|
US Patent 8,771,764 |
Title: Composition and method for improving vascular health
Issued: 8 July 2014 Assignee: Commonwealth Scientific and Industrial Research Organisation (50%), Malaysian Palm Oil Board (Malaysia, 50%) |
Description: This patent covers palm oil extracts useful for vasorelaxation.
|
US Patent 8,771,739 |
Title: Pharmaceutical compositions for poorly soluble drugs
Issued: 8 July 2014 Assignee: Mayne Pharma (ASX: MYC) |
Description: This patent covers the use of hydroxypropyl methylcellulose phthalate to improve drug water solubility.
|
US Patent 8,771,701 |
Title: Compositions for immunotherapy and uses thereof
Issued: 8 July 2014 Assignee: Burnet Institute |
Description: This patent application covers a method of pulsing dendritic cells with a combination of antigen and mannose.
|
US Patent 8,765,812 |
Description: This patent covers a TGF-beta inhibitor for the treatment of fibrotic conditions.
|
US Patent 8,765,700 |
Title: Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions
Issued: 1 July 2014 Assignee: Antisense Therapeutics (ASX: ANP) |
Description: This patent covers an antisense compound to VLA-4 for the treatment of asthma.
|
US Patent 8,765,677 |
Title: Omega conotoxin peptides
Issued: 1 July 2014 Assignee: University of Queensland (50%), University of Sydney (50%) |
Description: This patent covers peptides from cone shells for the treatment of neuropathic pain.
|
US Patent 8,765,183 |
Description: This patent covers polymer microgel beads incorporating nanomagnetic particles, useful in applications such the hyperthermic treatment of tissue.
|
US Patent 8,765,163 |
Description: This patent covers doped Hardystonite for tissue regeneration.
|
US Patent 8,765,144 |
Title: Antigenic complex for the diagnosis and treatment of Porphyromonas gingivalis infection
Issued: 1 July 2014 Assignee: University of Melbourne |
Description: This patent covers a P. gingivalis vaccine.
|
US Patent 8,759,286 |
Title: Pharmaceutical compositions comprising a VEGF-D polypeptide
Issued: 24 June 2014 Assignee: Opthea (ASX: OPT) |
Description: This patent covers the composition of matter of VEGF-D.
|
US Patent 8,758,728 |
Description: This patent covers a gel for transdermal drug delivery.
|
US Patent 8,748,406 |
Title: Preventive for adhesion following abdominal surgery
Issued: 10 June 2014 Assignee: Cellmid (ASX: CDY) |
Description: This patent covers the use of midkine to prevent post-surgical intraperitoneal adhesions.
|
US Patent 8,747,830 |
Title: Wound repair composition and method
Issued: 10 June 2014 Assignee: Queensland University of Technology |
Description: This patent covers a bisphosphonate matrix metalloproteinase inhibitor for wound care.
|
US Patent 8,741,970 |
Title: Composition and method for the enhancement of the efficacy of drugs
Issued: 3 June 2014 Assignee: Alchemia (ASX: ACL) |
Description: This patent covers the use of hyaluronanic acid as a chemopotentiator in chemotherapy.
|
US Patent 8,741,296 |
Title: Adenocarcinoma specific antibody SAM-6, and uses thereof
Issued: 3 June 2014 Assignee: Patrys (ASX: PAB) |
Description: This patent covers an antibody to the cancer target SAM-6.
|
US Patent 8,735,566 |
Title: Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
Issued: 27 May 2014 Assignee: EnGeneIC |
Description: This patent covers 'minicells', which are bacteria where functional nucleic acids can be packaged into the cells without the use of plasmids.
|
US Patent 8,735,173 |
Title: Multiplex screening for lysosomal storage disorders (LSDS)
Issued: 27 May 2014 Assignee: Women's and Children's Hospital, Adelaide |
Description: This patent covers methods to identify LSD enzymes in an automated multiplex assay.
|
US Patent 8,729,020 |
Title: Methods for the treatment of aortic fibrosis with VIP fragments
Issued: 20 May 2014 Assignee: Vectus Biosystems (ASX: VBS) |
Description: This patent covers the use of vasoactive intestinal peptide (VIP) fragment in treating aortic fibrosis.
|
US Patent 8,728,512 |
Title: Treatment and composition for wound healing
Issued: 20 May 2014 Assignee: Professor Christopher Jackson |
Description: This patent covers the use of Activated Protein C in wound healing.
|
US Patent 8,722,675 |
Description: This patent covers angiotensin II type 2 receptor antagonists for the treatment of neuropathic pain.
|
US Patent 8,722,634 |
Title: Use of compounds extracted from Momordica charantia L. in the manufacture of medicaments for prevention and treatment of diabetes and obesity
Issued: 13 May 2014 Assignee: Garvan Institute of Medical Research (50%), Shanghai Institute of Materia Medica, Chinese Academy of Sciences (China, 50%) |
Description: This patent covers extracts from the bitter melon plant, useful among other things as a glucose transporter.
|
US Patent 8,722,036 |
Title: Methods for treating malignancies using coxsackieviruses
Issued: 13 May 2014 Assignee: Viralytics (ASX: VLA) |
Description: This patent covers the mechanism of action of Viralytics' onclytic virus.
|
US Patent 8,716,222 |
Title: Methods and compositions for promoting organ development
Issued: 6 May 2014 Assignee: Kintan Pty Ltd |
Description: This patent covers the use of colony stimulating factor-1 protein (CSF-1) in promoting growth in premature-birthed warm blooded animals.
|
US Patent 8,715,724 |
Description: This patent covers the use of anti-static agents in tabletting drugs.
|
US Patent 8,710,015 |
Description: This patent covers synthetic version of the elastin protein, useful in skin repair.
|
US Patent 8,709,486 |
Description: This patent covers a method of keeping particulate material dispersed in its liquid carrier, which is particularly useful in the administration of contrast agents.
|
US Patent 8,709,425 |
Title: Antibodies to non-functional P2X7 receptor
Issued: 29 April 2014 Assignee: Biosceptre International |
Description: This patent covers antibodies to P2X7 , useful in inducing apoptosis in cancer cells.
|
US Patent 8,703,147 |
Title: Methods and compositions for treating and preventing malaria
Issued: 22 April 2014 Assignee: Walter and Eliza Hall Institute |
Description: This patent covers a malaria vaccine made from an erythrocyte binding antigen from a strain of Plasmodium falciparum.
|
US Patent 8,703,116 |
Description: This patent covers the combination of dendrimers with polyethelene glycol for longer half-life.
|
US Patent 8,697,702 |
Title: Method of optimizing the treatment of Philadelphia-positive leukemia with imatinib mesylate
Issued: 15 April 2014 Assignee: Medvet Science Pty Ltd (50%), Novartis (Switerland, 50%) |
Description: This patent covers a method of optimising Gleevec treatment by measuring octamer binding protein activity.
|
US Patent 8,697,678 |
Description: This patent a clear aqueous solution of the neuroactive steroid anaesthetic Alphaxalone.
|
US Patent 8,697,145 |
Title: Substances having body mass redistribution properties
Issued: 15 April 2014 Assignee: Horizon Science Pty Ltd (David Kannar and Barry Kitchen) |
Description: This patent covers a polyphenol-containing extract of molasses that treats obesity through inhibition of ACE.
|
US Patent 8,691,967 |
Title: Multiple promoter expression cassettes for simultaneous delivery of RNAi agents
Issued: 8 April 2014 Assignee: Benitec (ASX: BLT) |
Description: This patent covers expression cassettes for delivery of double-stranded RNA.
|
US Patent 8,691,963 |
Title: Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
Issued: 8 April 2014 Assignee: EnGeneIC |
Description: This patent covers the use of minicells in the treatment of cancer, in combination with chemotherapy.
|
US Patent 8,691,765 |
Title: Metallothionein based neuronal therapeutic and therapeutic methods
Issued: 8 April 2014 Assignee: University of Tasmania |
Description: This patent covers the use of metallothionein IIA for neuroprotection and neuroregeneration.
|
US Patent 8,686,110 |
Title: Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same
Issued: 1 April 2014 Assignee: Walter and Eliza Hall Institute |
Description: This patent covers proteins from the Bcl-2 superfamily suitable for inducing apoptosis in cancer cells.
|
US Patent 8,685,473 |
Description: This patent covers actives from Carica papaya useful in varuious indications including skin disorders.
|
US Patent 8,680,141 |
Description: This patent covers a natural product originally derived from Cinnamomum laubatii and useful as an anti-infective.
|
US Patent 8,673,872 |
Title: Method of modulation of expression of epidermal growth factor receptor(EGFR) involving miRNA
Issued: 18 March 2014 Assignee: University of Western Australia |
Description: This patent covers an microRNA-based EGFR inhibitor.
|
US Patent 8,673,586 |
Description: This patent covers a suite of kinase inhibitors.
|
US Patent 8,673,367 |
Description: This patent covers a silver-zinc formation with anti-microbial properties.
|
US Patent 8,673,363 |
Description: This protein covers the use of a bleaching gel with amorphous calcium phosphate in improving dental mineralisation.
|
US Patent 8,673,361 |
Title: Cytokine modulating composition
Issued: 18 March 2014 Assignee: Cambridge Scientific Pty Ltd (Maud Eijkenboom) |
Description: This patent covers the use of denatured plasma plus a metal in inhibiting cytokine activity.
|
US Patent 8,673,305 |
Title: Methods of treatment with antibodies against the extracellular loops of C5aR
Issued: 18 March 2014 Assignee: G2 Therapies |
Description: This patent covers Complement C5a receptors antibodies useful to treat inflammatory disorders.
|
US Patent 8,669,280 |
Description: This patent covers various substituted acylguanidines for used as anti-virals.
|
US Patent 8,669,101 |
Title: Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells
Issued: 11 March 2014 Assignee: EnGeneIC |
Description: : This patent covers the use of minicells in the treatment of cancer, in combination with chemotherapy.
|
US Patent 8,653,236 |
Description: This patent covers a DNA transposase from Brevibacterium linens with anti-cancer properties.
|
US Patent 8,652,511 |
Description: This patent covers a matrix patch for drug delivery.
|
US Patent 8,652,473 |
Title: Antibodies to EGF receptor epitope peptides and uses thereof
Issued: 18 February 2014 Assignee: Commonwealth Scientific and Industrial Research Organization (33%), Ludwig Institute for Cancer Research (US, 33%), Massachusetts Institute of Technology (US, 33%) |
Description: This patent covers anti-EGFR antibodies.
|
US Patent 8,642,731 |
Title: Porphyromonas gingivalis polypeptides and nucleotides
Issued: 4 February 2014 Assignee: CSL Ltd (ASX: CSL) (50%), University of Melbourne (50%) |
Description: : This patent covers a P. gingivalis vaccine.
|
US Patent 8,642,631 |
Title: Methods of treating mammals with eustachian tube dysfunctions
Issued: 4 February 2014 Assignee: University of Melbourne |
Description: This patent covers the use of betahistine in treating disorders such as otitis media.
|
US Patent 8,637,262 |
Title: Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
Issued: 28 January 2014 Assignee: Opthea (ASX: OPT) |
Description: This patent covers antibodies to VEGF-C.
|
US Patent 8,637,051 |
Title: Compositions and methods for treatment of mucosal infections
Issued: 28 January 2014 Assignee: Hunter Immunology |
Description: This patent covers the use of respiratory tract bacteria with lactic acid bacteria to provide protracted protection against mucosal infection.
|
US Patent 8,637,025 |
Title: Composition and method for the treatment and prevention of enteric bacterial infections
Issued: 28 January 2014 Assignee: Immuron (ASX: IMC) |
Description: This patent covers hyperimmunes to enteric bacteria from vaccines comprising one or more cell wall antigens.
|
US Patent 8,637,016 |
Title: EphA3 antibodies for the treatment of solid tumors
Issued: 28 January 2014 Assignee: Monash University (33%), KaloBios Pharmaceuticals (US, 33%), Ludwig Institute for Cancer Research (US, 33%) |
Description: This patent covers antibodies to EphA3, a receptor tyrosine kinase known as a cancer target.
|
US Patent 8,629,318 |
Title: Transgenic animals for analyzing CYP3A4 cytochrome P450 gene regulation
Issued: 14 January 2014 Assignee: University of Sydney |
Description: This patent covers an animal model for detecting cytochrome P450 toxicity.
|
US Patent 8,629,241 |
Title: Alpha helical mimics, their uses and methods for their production
Issued: 14 January 2014 Assignee: University of Queensland |
Description: This patent covers short chain peptides that form an alpha helicial conformation, useful for developing biomimetics.
|
US Patent 8,628,761 |
Title: Biodegradable polyurethane/urea compositions
Issued: 14 January 2014 Assignee: Polynovo (ASX: PNV) |
Description: This patent covers a biodegradable polymer useful in tissue repair.
|
US Patent 8,624,025 |
Description: This patent covers small molecules to treat human rhinovirus infection.
|
US Patent 8,623,354 |
Title: Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment
Issued: 7 January 2014 Assignee: Alchemia (ASX: ACL) |
Description: This patent covers the use of hyaluronic acid in combination of anti-cancer antibodies.
|
Copyright © 2016 NDF Research
